Education · not medical advice

GLP-1 half-life: how long these medications actually last

Semaglutide’s half-life is about a week. That single number explains weekly dosing, why levels take a month to plateau, and why one late shot barely moves the needle.

What “half-life” actually means

A drug’s half-life (t½) is the time it takes for the amount in your body to fall by half. It is a property of the molecule, not of you — but it is what determines how often a medication has to be taken, and how long it lingers after the last dose.

After one half-life, ~50% of a dose remains. After two, ~25%. After five, under 4% — which is why about five half-lives is the usual rule of thumb both for a drug washing out and for repeated doses reaching a stable level.

Half-life of each GLP-1 and incretin medication

Population averages from published pharmacokinetic studies and regulatory labels. Individual values vary; every figure links to its source.

MedicationHalf-life (t½)Time to peakDosingSteady stateSource
SemaglutideOzempic, Wegovy~168 h(~7 days)24–72 hWeekly~35 daysOzempic FDA label (DailyMed)
RetatrutideIn clinical trials — not an approved medicine~144 h(~6 days)12–48 hWeekly~30 daysUrva et al., Lancet 2022;400:1869–81 (PMID 36354040)
TirzepatideMounjaro, Zepbound~120 h(~5 days)24 h(median)Weekly~25 daysMounjaro FDA label (DailyMed)
DulaglutideTrulicity~120 h(~5 days)48 h(median)Weekly~25 daysTrulicity FDA label (DailyMed)
OrforglipronFoundayo~29–49 h4–8 hDaily~6–10 daysFoundayo (orforglipron) FDA label (DailyMed)
Semaglutide (oral)Rybelsus~168 h(~7 days)~1 hDaily~35 daysRybelsus FDA label (DailyMed)
LiraglutideVictoza, Saxenda~13 h8–12 hDaily~3 daysVictoza FDA label (DailyMed)

“Steady state” is roughly five half-lives — the point where the amount going in each week and the amount clearing out roughly balance. Where a study reports a range rather than a single figure, the range is shown. Rows marked “in clinical trials” are not approved medicines anywhere and cannot be prescribed. All values are estimates from published averages, not a measurement of you.

Why weekly dosing works

With a half-life near 7 days, semaglutide never fully clears between weekly injections — each dose lands on top of what is left of the last one. Levels climb for roughly 35 days before flattening out.

What a late or missed dose does

Tirzepatide’s half-life is about 5 days, so steady state takes roughly 25 days. A dose taken a day or two late moves the curve far less than most people expect — the long half-life is doing the smoothing.

What to do about a missed or late dose is a question for the label and your prescriber — this page describes the pharmacology, it does not tell you when to inject.

Common questions

How long does semaglutide stay in your system?

Semaglutide’s published half-life is about 168 hours (7 days), so roughly five half-lives — about five weeks — pass before the great majority of a final dose has cleared. That is a population average from published pharmacokinetics, not a measurement of any individual.

What is the half-life of tirzepatide?

About 120 hours (5 days) for the subcutaneous injection, with peak concentration around 24 hours after a dose. Steady state is reached in roughly 25 days of weekly dosing.

Is there a half-life calculator?

The arithmetic is simple: after each half-life, half of what remains is gone. This page lists the published half-life for each medication so you can work out roughly how much of a dose is left after a given number of days. The Glipath app draws the same curve continuously from your own logged doses.

Why does it take weeks to feel a dose change?

Because levels do not jump to a new plateau immediately. After a dose increase, it takes about five half-lives — weeks for these medications — for levels to settle at the new steady state.

Does half-life tell me what dose to take?

No. Half-life describes how a molecule behaves in the body on average. It says nothing about what dose is right for you, which is a decision for you and your prescriber using the approved label.

Tracking your doses, not just calculating them?
Log shots, track doses-per-vial & expiry, and plan your taper/off-ramp in the app.
Get the app →

Keep reading

Educational only — not medical advice and not a recommended dose. These are population averages from published pharmacokinetic studies, not a measurement of your body. Always follow your prescriber and the approved label.

Built by the makers of Glipath — the private GLP-1 companion for iPhone.Privacy ·Terms ·Support